Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Gibson

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Journal of the American College of Cardiology|October 5, 2001
Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategyD H Solomon, P H Stone, R J Glynn, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|February 1, 1993
Relation of vessel wall shear stress to atherosclerosis progression in human coronary arteriesC M Gibson, L Diaz, K Kandarpa, et al.
Journal of the American College of Cardiology|July 21, 1998
Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and RestenosisC M Gibson, M Goel, D J Cohen, et al.
Physical Chemistry Chemical Physics : PCCP|January 30, 2013
Capturing the elusive aromaticity of bicaliceneW P Oziminski, M Palusiak, J Dominikowska, et al.
The American Journal of Cardiology|February 17, 2001
Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials? TIMI Study GroupC M Gibson, S A Murphy, S J Marble, et al.
Journal of Thrombosis and Thrombolysis|April 15, 2000
The Open Artery Hypothesis: Past, Present, and FutureM Goel, J T Dodge, M Rizzo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 1, 2001
Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarctionC M Gibson, A J Kirtane, S A Murphy, et al.
The American Journal of Cardiology|December 13, 2000
Global impairment of coronary blood flow in the setting of acute coronary syndromes (a RESTORE substudy). Randomized Efficacy Study of Tirofiban for Outcomes and RestenosisC M Gibson, M Goel, S A Murphy, et al.
Clinical Pharmacology and Therapeutics|September 17, 2010
Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studiesD J Angiolillo, C M Gibson, S Cheng, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 4, 2000
Outcome of patients with acute myocardial infarction who are ineligible for primary angioplasty trialsH L Dauerman, D S Pinto, K K Ho, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Journal of the American College of Cardiology|October 5, 2001
Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategyD H Solomon, P H Stone, R J Glynn, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|February 1, 1993
Relation of vessel wall shear stress to atherosclerosis progression in human coronary arteriesC M Gibson, L Diaz, K Kandarpa, et al.
Journal of the American College of Cardiology|July 21, 1998
Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and RestenosisC M Gibson, M Goel, D J Cohen, et al.
Physical Chemistry Chemical Physics : PCCP|January 30, 2013
Capturing the elusive aromaticity of bicaliceneW P Oziminski, M Palusiak, J Dominikowska, et al.
The American Journal of Cardiology|February 17, 2001
Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials? TIMI Study GroupC M Gibson, S A Murphy, S J Marble, et al.
Journal of Thrombosis and Thrombolysis|April 15, 2000
The Open Artery Hypothesis: Past, Present, and FutureM Goel, J T Dodge, M Rizzo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 1, 2001
Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarctionC M Gibson, A J Kirtane, S A Murphy, et al.
The American Journal of Cardiology|December 13, 2000
Global impairment of coronary blood flow in the setting of acute coronary syndromes (a RESTORE substudy). Randomized Efficacy Study of Tirofiban for Outcomes and RestenosisC M Gibson, M Goel, S A Murphy, et al.
Clinical Pharmacology and Therapeutics|September 17, 2010
Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studiesD J Angiolillo, C M Gibson, S Cheng, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 4, 2000
Outcome of patients with acute myocardial infarction who are ineligible for primary angioplasty trialsH L Dauerman, D S Pinto, K K Ho, et al.
Pageof 10